Common complications of advanced cancer

K. A. Nelson, D. Walsh, O. Abdullah, F. McDonnell, J. Homsi, S. Komurcu, S. B. LeGrand, D. S. Zhukovsky

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Complications due to cancer and its treatment are common and increase in incidence and severity as the disease progresses. Central nervous system complications affect 15% to 20% of patients, and up to 75% have bone metastases at some point during the disease process. Endocrine abnormalities include hypercalcemia, adrenal insufficiency, and inappropriate antidiuretic syndrome. Hematologic disorders, malignant effusions, and gastrointestinal (GI) problems may cause significant morbidity. (C) 2000 W.B. Saunders Company.

Original languageEnglish (US)
Pages (from-to)34-44
Number of pages11
JournalSeminars in Oncology
Volume27
Issue number1
StatePublished - Mar 4 2000

Fingerprint

Adrenal Insufficiency
Hypercalcemia
Neoplasms
Central Nervous System
Neoplasm Metastasis
Morbidity
Bone and Bones
Incidence
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Nelson, K. A., Walsh, D., Abdullah, O., McDonnell, F., Homsi, J., Komurcu, S., ... Zhukovsky, D. S. (2000). Common complications of advanced cancer. Seminars in Oncology, 27(1), 34-44.

Common complications of advanced cancer. / Nelson, K. A.; Walsh, D.; Abdullah, O.; McDonnell, F.; Homsi, J.; Komurcu, S.; LeGrand, S. B.; Zhukovsky, D. S.

In: Seminars in Oncology, Vol. 27, No. 1, 04.03.2000, p. 34-44.

Research output: Contribution to journalArticle

Nelson, KA, Walsh, D, Abdullah, O, McDonnell, F, Homsi, J, Komurcu, S, LeGrand, SB & Zhukovsky, DS 2000, 'Common complications of advanced cancer', Seminars in Oncology, vol. 27, no. 1, pp. 34-44.
Nelson KA, Walsh D, Abdullah O, McDonnell F, Homsi J, Komurcu S et al. Common complications of advanced cancer. Seminars in Oncology. 2000 Mar 4;27(1):34-44.
Nelson, K. A. ; Walsh, D. ; Abdullah, O. ; McDonnell, F. ; Homsi, J. ; Komurcu, S. ; LeGrand, S. B. ; Zhukovsky, D. S. / Common complications of advanced cancer. In: Seminars in Oncology. 2000 ; Vol. 27, No. 1. pp. 34-44.
@article{40c3006e95fe43759a1fbb0d3be46935,
title = "Common complications of advanced cancer",
abstract = "Complications due to cancer and its treatment are common and increase in incidence and severity as the disease progresses. Central nervous system complications affect 15{\%} to 20{\%} of patients, and up to 75{\%} have bone metastases at some point during the disease process. Endocrine abnormalities include hypercalcemia, adrenal insufficiency, and inappropriate antidiuretic syndrome. Hematologic disorders, malignant effusions, and gastrointestinal (GI) problems may cause significant morbidity. (C) 2000 W.B. Saunders Company.",
author = "Nelson, {K. A.} and D. Walsh and O. Abdullah and F. McDonnell and J. Homsi and S. Komurcu and LeGrand, {S. B.} and Zhukovsky, {D. S.}",
year = "2000",
month = "3",
day = "4",
language = "English (US)",
volume = "27",
pages = "34--44",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Common complications of advanced cancer

AU - Nelson, K. A.

AU - Walsh, D.

AU - Abdullah, O.

AU - McDonnell, F.

AU - Homsi, J.

AU - Komurcu, S.

AU - LeGrand, S. B.

AU - Zhukovsky, D. S.

PY - 2000/3/4

Y1 - 2000/3/4

N2 - Complications due to cancer and its treatment are common and increase in incidence and severity as the disease progresses. Central nervous system complications affect 15% to 20% of patients, and up to 75% have bone metastases at some point during the disease process. Endocrine abnormalities include hypercalcemia, adrenal insufficiency, and inappropriate antidiuretic syndrome. Hematologic disorders, malignant effusions, and gastrointestinal (GI) problems may cause significant morbidity. (C) 2000 W.B. Saunders Company.

AB - Complications due to cancer and its treatment are common and increase in incidence and severity as the disease progresses. Central nervous system complications affect 15% to 20% of patients, and up to 75% have bone metastases at some point during the disease process. Endocrine abnormalities include hypercalcemia, adrenal insufficiency, and inappropriate antidiuretic syndrome. Hematologic disorders, malignant effusions, and gastrointestinal (GI) problems may cause significant morbidity. (C) 2000 W.B. Saunders Company.

UR - http://www.scopus.com/inward/record.url?scp=0033976338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033976338&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 34

EP - 44

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 1

ER -